We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies from this website.
OK |
More information
In Europe, non-adherence to treatments cost 125,000 million per year
07/02/13
News of "Acta sanitaria" that references the report published by the Pharmacy and Bioindustries Unit of Antares Consulting: "Economic impact of nonadherence in pharmaceutical costs"
